好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | C142 - Neuro-oncology: Navigating Current Trends

Tuesday 04/25/23
03:30 PM - 05:30 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Wendy Sherman, MD
Neuro-oncology
Participants will have increased knowledge regarding key clinical trial evidence supporting advancements in the treatment of primary and secondary central nervous system tumors, and integrate emerging evidence into treatment paradigms for patients with primary and secondary central nervous system tumors.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider
Case-based, Didactic
Event Timeline
03:30 PM - 04:00 PM EST Speaker Updates on Primary CNS Tumors
Michael W. Ruff, MD
04:00 PM - 04:30 PM EST Speaker Contemporary Approach to Metastatic Disease in the CNS
Tobias Walbert, MD, PhD, FAAN
04:30 PM - 05:00 PM EST Speaker Case Studies
Wendy Sherman, MD
05:00 PM - 05:30 PM EST Discussion Questions and Answers
Wendy Sherman, MD, Michael W. Ruff, MD, Tobias Walbert, MD, PhD, FAAN
Faculty Disclosures
Wendy Sherman, MD Dr. Sherman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Focused ultrasound foundation . Dr. Sherman has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Kiyatec.
Michael W. Ruff, MD Dr. Ruff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Radmetrix. Dr. Ruff has received intellectual property interests from a discovery or technology relating to health care.
Tobias Walbert, MD, PhD, FAAN Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AnHeart.